Becton, Dickinson and Co. | BDX - Assets

Stock Price
153.97
Daily Change
-0.54 -0.35%
Monthly
-6.94%
Yearly
-24.92%
Q2 Forecast
149.86

Becton, Dickinson and Co. reported $54.84B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Abbott USD 86.71B 2.53B Dec/2025
Agilent USD 12.81B 86M Dec/2025
Align Technology USD 6.23B 141K Dec/2025
AngioDynamics USD 269.68M 4.04M Sep/2025
Avanos Medical USD 1.07B 6M Dec/2025
Baxter International USD 20.06B 1.01B Dec/2025
Becton, Dickinson and Co. USD 54.84B 484M Dec/2025
Bio-Rad Laboratories USD 10.58B 880.1M Dec/2025
Boston Scientific USD 43.67B 966M Dec/2025
Cooper Companies USD 12.42B 29.4M Dec/2025
Danaher USD 83.46B 3.57B Dec/2025
Dentsply International USD 5.43B 224M Dec/2025
Dexcom USD 6.34B 1.16B Dec/2025
Edwards Lifesciences USD 13.27B 216.5M Sep/2025
Globus Medical USD 5.3B 207.12M Dec/2025
Hologic USD 9.18B 165.8M Dec/2025
Insulet USD 3.19B 161.1M Dec/2025
Integra LifeSciences USD 3.6B 44.45M Dec/2025
Intuitive Surgical USD 20.46B 1.11B Dec/2025
J&J USD 199.21B 6.39B Dec/2025
Masimo USD 1.7B 118.6M Dec/2025
Medtronic USD 91.48B 139M Dec/2025
Solventum Corp USD 14.29B 321M Dec/2025
Stryker USD 47.84B 787M Dec/2025
Tandem Diabetes Care USD 881.11M 6.46M Dec/2025
Teleflex USD 6.95B 924.7M Dec/2025
Terumo JPY 2.26T 362.12B Dec/2025
Thermo Fisher Scientific USD 110.34B 7.32B Dec/2025
Zimmer Biomet Holdings USD 23.09B 396.3M Dec/2025